<DOC>
	<DOCNO>NCT00828477</DOCNO>
	<brief_summary>The objective study evaluate compare comfort bromfenac nepafenac follow SLT .</brief_summary>
	<brief_title>Evaluation Comfort With Xibrom ( Bromfenac Ophthalmic Solution ) 0.09 % Nevanac ( Nepafenac Ophthalmic Suspension ) 0.1 % Following Selective Laser Trabeculoplasty ( SLT )</brief_title>
	<detailed_description>Open label , single arm , cross control study evaluate comfort IOP ( Intraocular Pressure ) change specific NSAIDs post SLT . Patients ( n= 25 , total 50 eye ) schedule undergo bilateral Selective Laser Trabeculoplasty ( SLT ) instill bromfenac first eye undergo SLT , contra lateral eye receive nepafenac .</detailed_description>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>&gt; 18 year old , either gender race . Diagnosis openangle glaucoma ocular hypertension require laser trabeculoplasty . Completion write informed consent/authorization prior study related procedure . Able follow study protocol likely complete study schedule . Known sensitivity NSAIDs . History neovascular ocular inflammatory disease . Current use topical systemic antiinflammatory medication . Females childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>